• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Ulcerative Colitis – Executive Market Summary 2011 Product Image

Ulcerative Colitis – Executive Market Summary 2011

  • ID: 1247183
  • May 2012
  • Region: Global
  • 18 Pages
  • Timely Data Resources, Inc

Executive Market Summaries were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Executive Market Summary provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. 

The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided.  

The Ulcerative Colitis Executive Market Summary 2011 provides an overview of the disease and related conditions, with incidence prevalence information for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the ulcerative colitis market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General description of the condition
Symptoms
Causes
Risk of colon cancer
Prognosis

II. INCIDENCE AND PREVALENCE
Incidence table (Canada, US, France, Germany, Italy, Spain, UK, Hong Kong, Japan, South Korea, Australia, Asia/Middle East, Europe, North America, Worldwide)
Prevalence table (Canada, US, Italy, UK, China, Japan, Singapore, South Korea, Asia/Middle East, Europe, North America, Worldwide)

III. DIAGNOSIS
Patient exam and history
Laboratory findings
Endoscopy
Imaging
Differential diagnosis

IV. TREATMENT
Treatment option by severity
Drug therapy
Hospitalization & Surgery

V. DOSING AND TREATMENT COSTS
Dosing for commonly prescribed drugs
Costs for commonly prescribed drugs

VI. MARKET SIZE
Overall market size
Sales information for key pharmaceuticals

VII. COMMENTS

VIII. REFERENCES/RESOURCES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos